Detalhe da pesquisa
1.
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Nat Immunol
; 21(5): 513-524, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284594
2.
Author Correction: Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Nat Immunol
; 21(9): 1135, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661365
3.
MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.
Proc Natl Acad Sci U S A
; 120(20): e2217635120, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37155847
4.
The Study of Remyelinating Therapies in Multiple Sclerosis: Visual Outcomes as a Window Into Repair.
J Neuroophthalmol
; 44(2): 143-156, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654413
5.
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Ann Neurol
; 91(2): 268-281, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878197
6.
Longitudinal Retinal Changes in MOGAD.
Ann Neurol
; 92(3): 476-485, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703428
7.
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
J Neurol Neurosurg Psychiatry
; 94(7): 560-566, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810323
8.
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Mult Scler
; 29(8): 945-955, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282545
9.
Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy.
Brain
; 145(11): 3943-3952, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678509
10.
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
Proc Natl Acad Sci U S A
; 117(37): 22932-22943, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859762
11.
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710320
12.
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Mult Scler
; 27(13): 2052-2061, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538237
13.
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Brain
; 143(4): 1127-1142, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293668
14.
Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis.
J Neuroophthalmol
; 41(4): 469-475, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33105412
15.
Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors.
J Neurosci
; 39(12): 2184-2194, 2019 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696729
16.
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Lancet
; 394(10206): 1352-1363, 2019 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495497
17.
Silent progression in disease activity-free relapsing multiple sclerosis.
Ann Neurol
; 85(5): 653-666, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851128
18.
Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis.
Mult Scler
; 26(3): 343-353, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32031464
19.
Early complement genes are associated with visual system degeneration in multiple sclerosis.
Brain
; 142(9): 2722-2736, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289819
20.
Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis.
J Neuroinflammation
; 16(1): 203, 2019 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31684959